在子宫肉瘤中复发的临床病理预测因素-一篇叙述性评论
Emmanuel N Kontomanolis1, Ioakeim Sapantzoglou2, Konstantinos Nikolettos3
1Department of Obstetrics and Gynecology, Democritus University, 67100 Alexandroupolis, Greece.
Journal of clinical medicine
|July 29, 2025
概括
本综述确定了临床,组织学和分子因素,预测子宫肉瘤的复发,如leiomyosarcomas. 需要进一步的研究来完善风险分层和个性化患者护理.
科学领域:
- 妇科瘤学 妇科瘤学
- 病理学 病理学 病理学
- 遗传学 是一个遗传学.
背景情况:
- 瘤是一种罕见的,多样化的恶性瘤,起源于介质细胞组织.
- 他们表现出各种各样的组织病理学,临床过程和治疗反应.
- 子宫肉瘤包括雷奥米奥萨尔科马,癌性肉瘤和子宫内膜层肉瘤.
研究的目的:
- 为了澄清临床病理学和分子预测器的复发在特定的子宫肉瘤.
- 增强对改善临床知识和患者护理的理解.
- 引导咨询实践和治疗策略.
主要方法:
- 文学综合结构化的叙事评论.
- 在PubMed/MEDLINE,Embase,Cochrane图书馆和Scopus中进行了搜索.
- 包括到2025年3月31日发表的文章.
主要成果:
- 总结了关于复发和不良预后的临床,组织学和分子预测因素的证据.
- 确定了阶段,等级,瘤大小和分子生物标志物作为高风险参数.
- 在现有数据中发现了矛盾的结果,突出了进一步研究的必要性.
结论:
- 下一代测序有助于识别患有复发和不良预后风险增加的妇女.
- 分层风险需要了解临床,组织学和分子因素.
- 这种知识对于有效的咨询,管理和个性化护理至关重要.
关键词:
癌症和肉瘤 (Carcinosarcoma) 是一种癌症.胚胎内膜层肉瘤 胚胎内膜层肉瘤雷奥米奥萨科马 (leiomyosarcoma) 是一种癌症.预测者 预测者 预测者复发性 复发性 复发性这是子宫肉瘤 (uterine sarcomas).更多相关视频
09:28Patient-derived Orthotopic Xenograft Models for Human Urothelial Cell Carcinoma and Colorectal Cancer Tumor Growth and Spontaneous Metastasis
Published on: May 12, 2019
10.3K
09:48An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells
Published on: September 12, 2019
8.2K
相关概念视频
02:07Tumor Progression
6.5K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.5K
02:40Cancer Stem Cells and Tumor Maintenance
5.0K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.0K